Statistical Considerations for Digitally-Derived Endpoints in Clinical Trials

Join the Food and Drug Administration (FDA) for a virtual public workshop, convened by the Duke…

Scaling Innovative Clinical Trial Approaches: Challenges, Progress, and Opportunities

WASHINGTON, DC

This hybrid workshop, co-convened by the Duke-Margolis Institute for Health Policy and the U.S…

Individualized Therapies on the RISE

WASHINGTON, DC

The current drug development paradigm and associated regulations were developed to test single…

On the RISE: Controls in Rare Disease Clinical Trials for Small and Diminishing Populations

WASHINGTON, DC

Conducting clinical trials in rare disease populations continues to pose many unique challenges,…